Category «Healthcare»

Toca 6 Trial Data Update: Tocagen Inc. (NASDAQ: TOCA)

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today is presenting data describing the tumor microenvironment and immunogenicity  of Toca 511 (vocimagene amiretrorepvec) & Toca FC (flucytosine, extended-release) in patients with solid tumor malignancies at the International Cancer Immunotherapy Conference hosted by The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European …